2.63
3.31%
-0.09
Handel nachbörslich:
2.63
Agenus Inc Aktie (AGEN) Neueste Nachrichten
Agenus Inc. (NASDAQ:AGEN) Short Interest Update - MarketBeat
William Blair Weighs in on Agenus' Q4 Earnings (NASDAQ:AGEN) - MarketBeat
Agenus (AGEN) Stock Dips Amid Financial Performance and Industry Trends - GuruFocus.com
Biotech Brass Misled Investors About Cancer Drugs, Suit Says - Law360
Agenus Top Brass Sued Over FDA Response to Cancer Drug Trial - Bloomberg Law
Agenus Inc. (NASDAQ:AGEN) Q3 2024 Earnings Call Transcript - Insider Monkey
Q3 2024 Agenus Inc Earnings Call - Cbainfo
Agenus Inc (AGEN) Q3 2024 Earnings Call Highlights: Navigating F - GuruFocus.com
Agenus Inc (AGEN) Q3 2024 Earnings Call Highlights: Navigating Financial Challenges While ... - Yahoo Finance
Agenus Inc. Reports Progress in Immunotherapy Development - TipRanks
Agenus: Q3 Earnings Snapshot - Houston Chronicle
Agenus Reports Third Quarter 2024 Financial Results - citybiz
Agenus (AGEN) Q3 2024 Earnings Call Transcript - AOL
Agenus reports Q3 EPS ($3.08) vs ($3.29) last year - TipRanks
HC Wainwright Issues Pessimistic Forecast for Agenus (NASDAQ:AGEN) Stock Price - MarketBeat
Agenus Inc (AGEN) Q3 2024 Earnings: EPS Miss, Revenue at $25.1M vs. $61.48M Estimate - GuruFocus.com
Agenus Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Agenus (AGEN) Reports Q3 Loss, Lags Revenue Estimates - Yahoo Finance
Agenus Q3 Revenue Edges Up Despite Cash Concerns; BOT/BAL Shows Promise in Cancer Trials | AGEN Stock News - StockTitan
Earnings To Watch: Agenus Inc (AGEN) Reports Q3 2024 Result - GuruFocus.com
Agenus stock hits 52-week low at $3.82 amid market challenges - Investing.com India
Agenus to Present Compelling Data on Botensilimab and AGEN1721 at SITC 2024 - Business Wire
Agenus to Showcase Breakthrough Cancer Immunotherapy Data at SITC 2024 Meeting | AGEN Stock News - StockTitan
Agenus (AGEN) Set to Announce Earnings on Tuesday - MarketBeat
AGEN LAWSUIT ALERT: Levi & Korsinsky Notifies Agenus Inc. Invest - GuruFocus.com
Agenus announces director Wiinberg's resignation and advisory role - Investing.com
AGENAgenus Inc. Latest Stock News & Market Updates - StockTitan
Agenus to Provide Third Quarter 2024 Financial Report and Corporate Update - Business Wire
Shareholders that lost money on Agenus Inc.(AGEN) should contact Levi & Korsinsky about pending Class ActionAGEN - PR Newswire
Levi & Korsinsky Reminds Agenus Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of November 5, 2024AGEN - PR Newswire
Investors in Agenus Inc. Should Contact Levi & Korsinsky Before November 5, 2024 to Discuss Your RightsAGEN - PR Newswire
Class Action Filed Against Agenus Inc. (AGEN)November 5, 2024 Deadline to Join – Contact Levi & Korsinsky - GlobeNewswire
The Gross Law Firm Announces the Filing of a Securities Class Action on Behalf of Agenus Inc.(AGEN) Shareholders - PR Newswire
ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Agenus - The Malaysian Reserve
AGEN Stockholders Have Opportunity to Lead Agenus Inc. Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today! - AccessWire
DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors - GlobeNewswire
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Agenus Inc. of Class Action Lawsuit and Upcoming DeadlinesAGEN - PR Newswire
Agenus stock hits 52-week low at $4.17 amid market challenges - Investing.com Australia
DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors of Agenus to Contact Us to Have Their Losses Evaluated Today - GlobeNewswire Inc.
Agenus stock hits 52-week low at $4.17 amid market challenges By Investing.com - Investing.com South Africa
AGEN INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Agenus Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - AccessWire
AGEN Investors Have Opportunity to Lead Agenus Inc. Securities F - GuruFocus.com
AGEN INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire
Agenus Inc. Sued for Securities Law ViolationsInvestors Should Contact The Gross Law Firm for More InformationAGEN - PR Newswire
Agenus Inc. Investors: Please contact the Portnoy Law Firm - GlobeNewswire
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Agenus - GlobeNewswire
AGEN Shareholders Have Opportunity to Lead Agenus Inc. Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today! - AccessWire
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Kapitalisierung:
|
Volumen (24h):